Silexion announces positive preclinical findings for SIL204, demonstrating key mechanism for endogenous systemic uptake in KRAS-driven cancers: Grand Cayman, Cayman Islands Tuesda ...
Timely access to basic screening, diagnosis is important for underserved communities in chronic conditions: Dr Huzaifa Khorakiwala: Our Bureau, Mumbai Tuesday, September 29, 2026, ...
MedGenome spotlights holistic heart health from public awareness to precision risk assessment: Our Bureau, Bengaluru Tuesday, September 29, 2026, 17:40 Hrs [IST] MedGenome has rel ...
Apollo Knowledge and BITS Pilani to advance healthcare research and build India's med-tech workforce
Apollo Knowledge and BITS Pilani to advance healthcare research and build India's med-tech workforce: Our Bureau, Bengaluru Tuesday, September 29, 2026, 17:35 Hrs [IST] Apollo Kno ...
Future of hospital surveillance is about data, not more cameras: Venkat Ramana: Our Bureau, Bengaluru Tuesday, September 29, 2026, 17:25 Hrs [IST] The future of hospital surveilla ...
Nearly 2 in 3 diagnostic bookings at Redcliffe Labs are preventive: Our Bureau, Mumbai Tuesday, September 29, 2026, 17:20 Hrs [IST] India is testing more proactively than ever. At ...
Tolerance Bio licenses clinical-stage anti-IL-33 monoclonal antibody from Tanabe Pharma to expand thymus-focused clinical pipeline: Philadelphia, Pennsylvania Tuesday, September 2 ...
Anupam Rasayan India Limited, one of India’s leading custom synthesis and specialty chemical companies, has paid the consideration towards the transaction of a 48.2% controlling stake in Bliss GVS ...
J P Nadda focuses on strengthening healthcare infrastructure, medical education: Our Bureau, Mumbai Tuesday, September 29, 2026, 16:35 Hrs [IST] Union minister for health and fami ...
Organon Canada announces approval and availability of Nduvra to treat moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older: Kirkland, Que ...
Akums Drugs receives DCGI approval for colchicine 0.5 mg tablets: Our Bureau, Mumbai Tuesday, September 29, 2026, 15:15 Hrs [IST] Akums Drugs & Pharmaceuticals Ltd., India’s lar ...
Mirum Pharmaceuticals’ phase 3 AZURE-1 study of brelovitug in chronic hepatitis delta virus meets primary endpoint: Foster City, California Tuesday, September 29, 2026, 15:00 Hr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results